The emergence of multi-drug resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) causes a major threat to public health due to its limited therapeutic options. There is an urgent need for the development of new effective antimicrobial agents and alternative strategies that are effective against resistant bacteria. This study aimed at the development of a reliable method for the extraction, purification, characterization, and quantification of cannabidiolic acid (CBDA) and its decarboxylated form cannabidiol (CBD).
CBD displayed a substantial inhibitory effect on Gram-positive bacteria with minimal inhibitory concentrations ranging from 1 to 2 µg/mL. Time kill analysis and minimal bactericidal concentration revealed potential bactericidal activity of CBDA and CBD.
Sativa Wellness Group (AQSE:SWEL) goal is to be recognised as one of the leading health companies, through building the best wellness brands in CBD testing services and products, to meet today’s fast evolving consumer expectations. Through full vertical integration of their supply chain and expansion of their distribution network, they plan to become one of the premier producers and high-quality distributors of CBD and wellness products and services in Europe.